Assessment of measles immunity among infants in Maputo City, Mozambique

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Jani, Jagrati V ^a,b   Holm Hansen, Carol ^c   Mussá, Tufária ^a   Zango, Arlinda ^a   Manhiça, Ivan ^a   Bjune, Gunnar ^b   Jani, Ilesh V ^a  

^a Instituto Nacional de Saúde   (Mozambique)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEASLES VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; EPIDEMIOLOGY; HUMAN; IMMUNITY; IMMUNOLOGY; INFANT; MASS IMMUNIZATION; MEASLES; MEASLES VIRUS; MOTHER; MOUTH MUCOSA; MOZAMBIQUE; URBAN POPULATION; VIROLOGY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MASS IMMUNIZATION; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MOTHERS; MOUTH MUCOSA; MOZAMBIQUE; SEROEPIDEMIOLOGIC STUDIES; URBAN POPULATION; YOUNG ADULT;

EID: 60849107763     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-386     Document Type: Article

References (38)

1. Health, development and the Millennium Development Goals. R Dodd A Cassels, Annals of tropical medicine and parasitology 2006 100 5-6 379 387 10.1179/136485906X97471
2. Global measles elimination. WJ Moss DE Griffin, Nat Rev Microbiol 2006 4 12 900 908 10.1038/nrmicro1550 17088933
3. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months. FT Cutts O Monteiro P Tabard J Cliff, Bull World Health Organ 1994 72 2 227 231 8205642
4. Assessment of routine surveillance data as a tool to investigate measles outbreaks in Mozambique. JV Jani IV Jani C Araujo S Sahay J Barreto G Bjune, BMC Infect Dis 2006 6 29 16504049 10.1186/1471-2334-6-29
5. Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001). J Cliff A Simango O Augusto L Van Der Paal R Biellik, J Infect Dis 2003 187 Suppl 1 S51 57 10.1086/368058 12721891
6. The 1992 measles epidemic in Cape Town-a changing epidemiological pattern. N Coetzee GD Hussey G Visser P Barron A Keen, S Afr Med J 1994 84 3 145 149 7740350
7. After the honeymoon in measles control. AR McLean, Lancet 1995 345 8945 272 10.1016/S0140-6736(95)90272-4 7837860
8. Measles and pertussis in developing countries with good vaccine coverage. K Mulholland, Lancet 1995 345 8945 305 307 10.1016/S0140-6736(95)90282-1 7837867
9. Experience in global measles control, 1990-2001. AM Henao-Restrepo P Strebel E John Hoekstra M Birmingham J Bilous, J Infect Dis 2003 187 Suppl 1 S15 21 10.1086/368273 12721887
10. Public-health impact of accelerated measles control in the WHO African Region 2000-03. M Otten R Kezaala A Fall B Masresha R Martin L Cairns R Eggers R Biellik M Grabowsky P Strebel, Lancet 2005 366 9488 832 839 10.1016/S0140-6736(05)67216-9 16139658
11. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002. MW Otten Jr JM Okwo-Bele R Kezaala R Biellik R Eggers D Nshimirimana, J Infect Dis 2003 187 Suppl 1 S36 43 10.1086/368272 12721884
12. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. MD Tapia SO Sow S Medina-Moreno Y Lim MF Pasetti K Kotloff MM Levine, Am J Trop Med Hyg 2005 73 1 26 31 16014826
13. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. R Dagan PE Slater P Duvdevani N Golubev E Mendelson, Pediatr Infect Dis J 1995 14 11 965 969 8584363
14. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. F Enquselassie W Ayele A Dejene T Messele A Abebe FT Cutts DJ Nokes, Epidemiol Infect 2003 130 3 507 519 12825737
15. Future applications of oral fluid specimen technology. JR George JH Fitchen, Am J Med 1997 102 4A 21 25 10.1016/S0002-9343(97)00034-X 9217635
16. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. DJ Nokes F Enquselassie W Nigatu AJ Vyse BJ Cohen DW Brown FT Cutts, Bull World Health Organ 2001 79 7 588 595 11477961
17. Pre-and post-vaccine measles antibody status in infants using serum and oral-fluid testing: An evaluation of routine immunization in Addis Ababa, Ethiopia. W Nigatu DJ Nokes BJ Cohen DWG Brown AJ Vyse, Ethip J Health Dev 2003 17 3 149 155
18. Evaluation of the measles clinical case definition. SS Hutchins MJ Papania R Amler EF Maes M Grabowsky K Bromberg V Glasglow T Speed WJ Bellini WA Orenstein, J Infect Dis 2004 189 Suppl 1 S153 159 10.1086/379652 15106104
19. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies. FT Cutts A Bartoloni P Guglielmetti F Gil D Brown ML Bianchi Bandinelli M Roselli, Trans R Soc Trop Med Hyg 1995 89 1 119 122 10.1016/0035-9203(95)90683-5 7747295
20. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. DJ Nokes F Enquselassie A Vyse W Nigatu FT Cutts DW Brown, Trans R Soc Trop Med Hyg 1998 92 6 679 685 10.1016/S0035-9203(98)90811-2 10326122
21. Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). W Nigatu DJ Nokes F Enquselassie DW Brown BJ Cohen AJ Vyse FT Cutts, J Virol Methods 1999 83 1-2 135 144 10.1016/S0166-0934(99)00116-0 10598091
22. Measles elimination in the Americas. Evolving strategies. CA de Quadros JM Olive BS Hersh MA Strassburg DA Henderson D Brandling-Bennett GA Alleyne, Jama 1996 275 3 224 229 10.1001/jama.275.3.224 8604176
23. Measles vaccination policy. BG Williams FT Cutts C Dye, Epidemiol Infect 1995 115 3 603 621 8557092
24. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. S Ratnam V Gadag R West J Burris E Oates F Stead N Bouilianne, J Clin Microbiol 1995 33 4 811 815 7790442
25. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test. BJ Ward S Aouchiche N Martel FM Bertley N Bautista-Lopez B Serhir S Ratnam, Diagn Microbiol Infect Dis 1999 33 3 147 152 10.1016/S0732-8893(98)00069-8 10092962
26. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. E Vardas S Kreis, J Clin Virol 1999 13 3 173 179 10.1016/S1386-6532(99)00026-8 10443793
27. IgG & IgM antibodies against measles virus in unvaccinated infants from Pune: evidence for subclinical infections. SR Prasad NJ Shaikh S Verma K Banerjee, Indian J Med Res 1995 101 1 5 7883277
28. Anthropometric indicators of nutritional status: implications for fitness, activity, and health in school-age children and adolescents from Maputo, Mozambique. A Prista JA Maia A Damasceno G Beunen, The American journal of clinical nutrition 2003 77 4 952 959 12663297
29. Estimating the date of confinement: ultrasonographic biometry versus certain menstrual dates. M Mongelli M Wilcox J Gardosi, Am J Obstet Gynecol 1996 174 1 Pt 1 278 281 10.1016/S0002-9378(96)70408-8 8572021
30. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. DA Savitz JW Terry Jr N Dole JM Thorp Jr AM Siega-Riz AH Herring, Am J Obstet Gynecol 2002 187 6 1660 1666 10.1067/mob.2002.127601 12501080
31. Maternally derived measles immunity in era of vaccine-protected mothers. JL Lennon FL Black, J Pediatr 1986 108 5 Pt 1 671 676 3701511
32. Maternally derived measles immunity in children of naturally infected and vaccinated mothers. PJ Jenks EO Caul AP Roome, Epidemiol Infect 1988 101 2 473 476 3053223
33. Evaluation of commercial assay detecting specific immunoglobulin g in oral fluid for determining measles immunity in vaccinees. JR Kremer CP Muller, Clin Diagn Lab Immunol 2005 12 5 668 670 15879031 10.1128/CDLI.12.5.668-670.2005
34. Measles mortality and vaccine efficacy in rural West Africa. HF Hull PJ Williams F Oldfield, Lancet 1983 1 8331 972 975 10.1016/S0140-6736(83)92091-3 6132278
35. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. H Gans L Yasukawa M Rinki R DeHovitz B Forghani J Beeler S Audet Y Maldonado AM Arvin, J Infect Dis 2001 184 7 817 826 10.1086/323346 11528592
36. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. SR Permar WJ Moss JJ Ryon M Monze F Cutts TC Quinn DE Griffin, J Infect Dis 2001 183 4 532 538 10.1086/318533 11170977
37. Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. K Vainio HH Samdal G Anestad E Wedege DH Skutlaberg KT Bransdal R Mundal IS Aaberge, Eur J Clin Microbiol Infect Dis 2008 27 6 461 465 10.1007/s10096-008-0460-3 18293018
38. High measles mortality in infancy related to intensity of exposure. P Aaby J Bukh G Hoff J Leerhoy IM Lisse CH Mordhorst IR Pedersen, J Pediatr 1986 109 1 40 44 10.1016/S0022-3476(86)80569-8 3723239